Background--Multiple studies have shown that an NO-induced activation of vascular smooth muscle BK channels contributes to the NO-evoked dilation in many blood vessels. In vivo, NO is released continuously. NO attenuates vessel constrictions and, therefore, exerts an anticontractile effect. It is unknown whether the anticontractile effect of continuously present NO is mediated by BK channels.
channels. 5, 6 Alternatively, NO has been reported to directly modulate BK channels. 7 Multiple studies have shown that an NO-induced activation of vascular smooth muscle BK channels contributes to the NO-evoked dilation in many blood vessels [8] [9] [10] [11] (additional studies listed and discussed by Tanaka et al 12 ).
In vivo, the bloodstream is continually exerting shear stress on the vessel wall, leading to a continuous release of NO. The vessel wall is, therefore, constantly exposed to NO. NO then attenuates vessel constrictions induced by, for example, transmitters released from nerve endings or circulating hormones: NO exerts an anticontractile effect. It is unknown whether the anticontractile effect of continuously present NO is also mediated by BK channels. This question may not seem exciting in light of the overwhelming evidence demonstrating that BK channels mediate vasodilation induced by NO (see studies listed and discussed by Tanaka et al 12 ). However, even in these studies, reported findings have varied. Indeed, the BK channel blockers charybdotoxin or iberiotoxin did not affect Snitroso-N-acetylpenicillamine-induced relaxation of guinea pig aorta and carotid arteries, 13 3-morpholino-sydnonimineinduced hyperpolarization of rabbit mesenteric arteries, 14 sodium nitroprusside (SNP)-induced hyperpolarization of guinea pig carotid arteries, 15 and 3-morpholino-sydnonimineinduced relaxation of rabbit carotid arteries. 16 Thus, a contribution of the BK channel to the vasodilatory effect of NO cannot be predicted clearly, even less so for the never studied anticontractile effect of permanently present NO. Therefore, this study tested the hypothesis that BK channels mediate the vasodilatory effect of continuously present NO.
Methods
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. The authors declare that all supporting data are available within the article (and its online supplementary files).
Animals
This investigation conforms with the US Guide for the Care and Use of Laboratory Animals (8th edition, National Academy of Sciences, 2011) and institutional guidelines. A governmental committee on animal welfare granted approval for the use of laboratory animals in this study. Male, 8 to 12 weeks old, Wistar rats (n=267) and male, 6 to 10 weeks old, C57BL/6 mice (n=15) were obtained from Janvier (France). Male, 6 to 10 weeks old, BKb1-deficient mice (n=17) (targeted disruption of BK channel b1 locus: exon 1 deleted) were kindly provided by Prof. Olaf Pongs (University Hamburg) and have been described previously. 17 The animals were provided with food and water ad libitum and were housed under standardized conditions in a room with a controlled temperature (22°C) and a 12-hour light-dark cycle.
Vessel Preparation
The rats were euthanized under CO 2 narcosis by decapitation, and mice were euthanized under isoflurane narcosis by decapitation. The tail and the lower extremity (limb) were quickly removed and placed in an ice-cold physiological saline solution of the following composition (in mmol/L): 145 NaCl, 4.5 KCl, 1.2 NaH 2 PO 4 , 0.1 CaCl 2 , 1.0 MgSO 4 , 0.025 EDTA, and 5 HEPES (pH 7.4). The tail and saphenous arteries were isolated by removing all surrounding tissues. Small vessel rings (2 mm in length) were used for further experiments. The rat tail artery was selected because we had characterized vascular smooth muscle BK channel properties and regulation previously. 18, 19 Although not being used in studies on BK channels, the rat saphenous artery has been used intensively in other projects and was, therefore, also chosen for the present study.
20,21

Isometric Mounting of Vessels
For the recording of isometric tension, isolated vessels were mounted onto 2 stainless steel wires in a wire myograph (model 610M; Danish Myotechnology, Denmark) filled with physiological salt solution (PSS), consisting of (in mmol/L): 120 NaCl, 4. What Are the Clinical Implications?
• In several diseases, such as hypertension and diabetes mellitus, an impaired BK channel function has been observed.
• Previously, the latter was considered to lead to a reduced NO-induced vasodilation.
• The new data propose that the opposite may be the case.
was tested with the following: (1) methoxamine at 10 À5 mol/ L to test smooth muscle cell function; and (2) acetylcholine at 10 À5 mol/L after preconstriction with 10 À6 mol/L methoxamine to test endothelial cell function. In some experiments, a solution containing 120 mmol/L KCl was used, which was prepared on the basis of PSS by equimolar replacement of NaCl. All vessel tension data were normalized to the tension developed in response to 10 À5 mol/L methoxamine, applied after the viability test. In most cases, the vessel response of interest was a cumulative concentration-response relationship to methoxamine. Herein, the response of the vessel to a particular concentration of methoxamine, except the lowest one, was dependent on the response to the preceding methoxamine concentration. To avoid dealing with interdependent data during statistical analysis, the concentrationresponse relationships were characterized by just 1 parameter: their area under the curve.
Functional Removal of the Endothelium
In all experiments, except the series testing the effect of acetylcholine and carbachol, the endothelium of the vessels was removed by mechanical disruption using a rat whisker. Functional removal of the endothelium was considered successful when acetylcholine-induced vasodilation was absent during the viability test.
Experimental Protocol
Most experiments were performed using a standardized protocol ( Figure S1 ). Each vessel was assigned to a particular experimental group: either the control group or 1 of the treatment groups (eg, iberiotoxin, SNP, and iberiotoxin+SNP; all experimental groups belonging to a particular experimental series are thus determined by the corresponding figure legend). After the viability test, all vessels were challenged with increasing concentrations of methoxamine in the range from 10 À8 to 10 À5 mol/L applied cumulatively in half-log steps for predefined durations. Reliable comparisons of vessel responses between groups required that the vessels in these groups possess the same average initial contractility. Therefore, the average concentration-response relationships to methoxamine obtained directly after the viability test had to be similar ( Figure S1A ). This was routinely tested in all experimental series. In many experimental groups, vessels were pretreated with the BK channel inhibitor iberiotoxin after methoxamine washout. If this was the case, distilled water, which is the solvent of iberiotoxin, was applied to a control group at the same time. Afterwards, concentrationresponse relationships to methoxamine were obtained again. Reliable comparisons of vessel responses between groups required that all vessels exposed to iberiotoxin possess the same average contractility. Therefore, in this case, the average concentration-response relationships to methoxamine of the iberiotoxin groups also had to be similar ( Figure S1B ). The same requirements were applied to all vessels exposed to the solvent ( Figure S1B ). This was routinely tested in all experimental series. Finally, after the washout of all drugs applied, the substances to be studied (eg, SNP) were added to the respective experimental groups, and treatments (eg, iberiotoxin) were repeated. Then, concentration-response relationships to methoxamine were obtained again. The latter were used to evaluate the effects studied and are presented in the figures. calcium influx from the extracellular space, (2) it evokes calcium release from intracellular stores and empties the latter, and (3) it renders calcium pumps and transporters ineffective. 23 
Drugs and Chemicals
Acetylcholine, b-cyano-L-alanine, caffeine, carbachol, diethylenetriamine/NO, hydroxycobalamin, ionomycin, methoxamine, rhodanese, sodium cyanide, SNP, and sodium thiosulfate were obtained from Sigma. S-nitroso-N-acetylpenicillamine and the salts for the solutions were from Merck. Barium chloride was from Riedel de Haen. Iberiotoxin and stromatoxin were purchased from Alomone Labs. Cyclopiazonic acid, diphenyl phosphine oxide-1, glibenclamide, nimodipine, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, ryanodine, and XE991 were obtained from Tocris (UK). Rp-8-Br-PET-cGMPS was purchased from Biolog, NG-nitro-L-arginine was purchased from Alexis, and FURA 2-AM was purchased from Life Technologies.
Statistical Analysis
All values are given as meanAESEM. N is the number of animals tested. Statistical analysis was performed using GraphPadPrism 6.0. The statistical method used is provided in the figure legends for each particular analysis. Independent-sample t test, paired-sample t test, repeated-measures ANOVA, and 2-way ANOVA were used. For ANOVA, the interaction and/or the effect of the specific treatment was analyzed. The data of the methoxamine concentrationresponse relationships were obtained during cumulative addition of methoxamine. They are, thus, interdependent. To avoid this issue during statistical analysis, these relationships were represented by a single parameter: their area under the curve. P<0.05 was considered statistically significant.
Results
Contribution of the BK Channel to the Anticontractile Effect of NO
To study the anticontractile effect of NO, vasoconstrictorinduced vessel responses were investigated in the absence and presence of the NO donor, SNP. Vasoconstriction of rat tail arteries was evoked by the selective a1-adrenoceptor agonist, methoxamine. 24 Methoxamine produced a concentration-dependent contraction ( Figure 1A , CONTROL). In the presence of SNP, the methoxamine concentration-response relationship was shifted to the right compared with the control, demonstrating the anticontractile effect of SNP ( Figure 1A ). The methoxamine concentration-response relationships were compared by their area under the curve (for details, see Methods). Accordingly, the anticontractile effect of SNP was quantified as the area between the methoxamine-induced concentration-response relationships obtained in the absence and in the presence of SNP ( Figure 1C ). This analysis showed that SNP produced a concentration-dependent shift of the methoxamine concentration-response relationship to the right ( Figure 1D , CONTROL).
To study the contribution of the BK channel to the anticontractile effect of SNP, the BK channel blocker iberiotoxin was used at a saturating concentration, 25 used in the vast majority of studies on BK channels. In the presence of iberiotoxin, the SNP-induced shift to the right of the methoxamine concentration-response relationship was also observed ( Figure 1B ). However, in contrast to expectation, the anticontractile effect of SNP was greater when the BK channel was blocked compared with when it was not blocked ( Figure 1D ). More important, this unexpected finding was reproduced by other NO donors, like S-nitroso-N-acetylpenicillamine ( Figure S3A ) and diethylenetriamine-NO ( Figure S3B ). Because of a much lower rate of NO release, diethylenetriamine-NO had to be used at higher concentrations compared with the other NO donors. 26 The new finding was also reproduced with acetylcholine ( Figure S3C ) and its more stable analog, carbachol ( Figure S3D ). As expected, the effect of the latter was mediated by NO released from the endothelium, because its effect was blocked completely by the endothelial NO synthase inhibitor NG-nitro-L-arginine ( Figure S3D ). A major contribution of NO to acetylcholineinduced vasodilation has previously been shown for the vessel studied. 27, 28 To examine the contribution of the BK channel to the anticontractile effect of SNP in more detail, the functional availability of the BK channel was determined by comparing methoxamine-induced contractions in the absence and presence of iberiotoxin. When methoxamine-induced contractions in the absence and presence of iberiotoxin were indistinguishable and, therefore, BK channels were not able to affect the methoxamine-induced response, we considered BK channels to be functionally unavailable. However, when methoxamine-induced contractions in the absence and presence of iberiotoxin were different and BK channels affected the methoxamine-induced vessel response, we considered BK channels to be functionally available. Our data showed that methoxamine-induced contractions in the presence of iberiotoxin were larger than in the absence of iberiotoxin. The functional availability of the BK channel was quantified as the area between the methoxamine-induced concentrationresponse relationships obtained in the absence and in the presence of iberiotoxin ( Figure 2C ). In the presence of SNP, the functional availability of the BK channel was decreased at several SNP concentrations (Figure 2A , 2B, and 2D). This finding was reproduced by other NO donors, like S-nitroso-Nacetylpenicillamine ( Figure S4A ) and diethylenetriamine-NO ( Figure S4B ), as well as by acetylcholine ( Figure S4C ) and its more stable analog, carbachol ( Figure S4D ).
More important, similar effects were observed in the saphenous artery of the rat: a greater anticontractile effect of SNP in the presence of iberiotoxin ( Figure S5A through S5C) and a decreased functional availability of the BK channel in the presence of SNP ( Figure S5A , S5B, and S5D).
Moreover, similar effects were also observed in mouse tail arteries: a greater anticontractile effect of SNP in the presence of iberiotoxin ( Figure S6A through S6C) and a decreased functional availability of the BK channel in the presence of SNP ( Figure S6A , S6B, and S6D).
Involvement of NO in the Anticontractile Effect of SNP
It has previously been reported that SNP can release cyanide along with NO when in contact with vessel tissue. 29 Therefore, it was clarified whether NO or cyanide mediates the effects of SNP previously described. First, in the presence of the NO scavenger hydroxycobalamin 30 at 10 À3 mol/L, the anticontractile effect of SNP was abolished À8 mol/L; *n=9, P<0.001; n=7, P<0.001; n=7, P<0.001 for SNP 10 À7 , 10 À6 , and 10 À5 mol/L, respectively). C, The anticontractile effect of SNP represented as the area (marked in gray) between the MX-induced concentration-response relationships obtained in the absence (CONTROL) and in the presence of SNP (SNP). D, The anticontractile effect of SNP, quantified as described in C, in the absence (CONTROL) and presence of IbTX (2-way ANOVA for effect of SNP: P<0.001; *2-way ANOVA control vs IbTX: P<0.001; post hoc analysis: n=9, P<0.01; n=7, P<0.05; n=7, P<0.05 for SNP 10 À7 , 10 À6 , and 10 À5 mol/L, respectively).
( Figure S7A and S7B), including its effect on the BK channel ( Figure S7A and S7C) . Second, pretreatment of vessels with 30 U/L rhodanese and 1.25910 À4 mol/L sodium thiosulfate, 31 which inactivate cyanide by transferring the sulfane sulfur from thiosulfate to cyanide to form thiocyanide and sulphite, 32 did not alter the anticontractile effect of SNP ( Figure S8A and S8B) or its effect on the BK channel ( Figure S8A and S8C) . Third, cyanide itself did not show an anticontractile effect ( Figure S9A and S9B), nor did it influence BK channel functional availability ( Figure S9A and S9C) .
Finally, it has been reported that SNP can directly interact with H 2 S, leading to the generation of nitroxyl, and that the latter could be responsible for the observed functional effects. 33 Pretreatment of vessels with 3910 À3 mol/L bcyano-L-alanine, an inhibitor 34 of the major H 2 S-generating enzymes cystathionine c-lyase and cystathionine b-synthase in vascular tissue, 35 somewhat reduced the anticontractile effect of SNP ( Figure S10A and S10B ). Yet, in the presence b-cyano-Lalanine, the anticontractile effect of SNP was greater when the BK channel was blocked, compared with when it was not blocked ( Figure S10B ), and functional availability of the BK channel was decreased in the presence of SNP ( Figure S10C ).
Guanylyl Cyclase and PKG Pathway in the Anticontractile Effect of SNP
It has previously been reported that SNP induces an increase of cGMP. 36 This suggests that SNP activates the guanylyl cyclase/PKG pathway. Application of the selective guanylyl cyclase Figure 3A and 3B) and its effect on the BK channel completely ( Figure 3A and 3C ). In the presence of 10 À5 mol/L Rp-8-Br-PET-cGMPS, a selective PKG inhibitor, 38 the anticontractile effect of SNP ( Figure 3D and 3E) and its effect on the BK channel ( Figure 3D and 3F) were reduced. In the presence of SNP, the methoxamine concentrationresponse relationship for [Ca 2+ ] i was shifted to the right, compared with the control (Figure 4A) , similar to the effect of SNP on methoxamine-induced tension (as previously described).
In the presence of iberiotoxin, the SNP-induced shift to the right of the methoxamine concentration-response relationship for [Ca 2+ ] i was also observed ( Figure 4B ). ] i store content was estimated by applying the calcium-ionophore ionomycin in the presence of EGTA in the extracellular solution (for more detail, see Methods). 23 The increase in [Ca 2+ ] i produced by 10 À5 mol/L ionomycin was also not altered by SNP ( Figure 5C ). In contrast, when calcium release was eliminated by pretreating vessels with the widely used sarco/endoplasmic reticulum Ca ] i was shifted to the right in the presence of SNP ( Figure 5D ). Notably, under these conditions, the methoxamine-induced increase in [Ca 2+ ] i was prevented completely by vessel pretreatment with 10 À6 mol/L nimodipine, an established blocker of Ltype voltage-dependent calcium channels (VOCs) ( Figure 5D ).
Involvement of Changes in Calcium Influx in the Anticontractile Effect of SNP
The reduction of calcium influx via VOCs by SNP may result from an SNP-induced opening of non-BK potassium channels, 39 leading to cell membrane hyperpolarization and a subsequent closure of VOCs. However, when most non-BK potassium channels known to be expressed in vascular smooth muscle were inhibited by a blocker mixture (which contained the Kv1 channel blocker diphenyl phosphine oxide-1 at 10 À6 mol/L, 40 Figure S11A and S11B) and a decreased functional availability of the BK channel in the presence of SNP ( Figure S11A and S11C) were still observed. When the indirect potassium channel-mediated effects of SNP on VOC were eliminated by either precontracting vessels with 120 mmol/L KCl or applying the previously mentioned blocker mixture, including 10 À7 mol/L iberiotoxin, SNP produced relaxation ( Figure S11D ) associated with a decrease in [Ca 2+ ] i ( Figure S11E ).
Finally, in tail arteries of BK channel b1-subunit-deficient mice, 17 SNP produced an anticontractile effect ( Figure 6A through 6C), but this effect was not augmented anymore in the presence of iberiotoxin ( Figure 6A through 6C), and SNP had no effect on the functional availability of the BK channel ( Figure 6A , 6B, and 6D).
Discussion
The present study revealed 8 major findings. First, continuously present NO donors (SNP, S-nitroso-N-acetylpenicillamine, and diethylenetriamine-NO), and endogenously produced NO, released in response to acetylcholine and carbachol, evoke an anticontractile effect. Second, these substances produce a greater anticontractile effect in the 
Anticontractile Effect of NO Donors Is Mediated by NO
NO is a gas that is difficult to handle. Therefore, in almost all experimental studies, as well as in clinical practice, 45, 46 NO donors are used. However, NO donors may evoke their effects, at least partly, independently of NO. 45, 46 Yet, this seems not to be the case in the present study. First, 3 different NO donors, SNP, S-nitroso-N-acetylpenicillamine, and diethylenetriamine-NO, possessing different properties, except the ability to release NO, produced identical effects. Moreover, the same effects were evoked by acetylcholine and carbachol, known to release endogenous NO from vascular endothelium. 27, 28 This was also observed in the present study, where their effects were blocked by NG- nitro-L-arginine, an established endothelial NO synthase inhibitor. Second, the presented data show that the effects of the most often used NO donor in this study (SNP) were abolished by hydroxycobalamin, an NO scavenger. 30 Also, its effects
were not mimicked by cyanide, previously reported to be released from SNP along with NO. 29 Furthermore, the effects were not affected by rhodanese and sodium thiosulfate, 31 which inactivate cyanide. 32 Finally, the effects of SNP were also unaltered by b-cyano-L-alanine, an inhibitor 34 of cystathionine c-lyase and cystathionine b-synthase, the major H 2 S-producing enzymes in vascular tissue. 35 H 2 S has been reported to interact directly with SNP, leading to the generation of nitroxyl responsible for the functional observed effects. 33 Third, in line with the established opinion that the vasodilatory effect of NO is mediated by the soluble guanylyl cyclase/ PKG signaling pathway, 3, 4 the effects of SNP observed in the present study were as follows: (1) inhibitor, Rp-8-Br-PET-cGMPS. 38 Rp-8-Br-PET-cGMPS at concentrations higher than the one used in the present study may stimulate basal PKG activity. 47, 48 Consequently, such Rp-8-Br-PET-cGMPS concentrations were not used, even if they may be required for the complete inhibition of PKG.
47,48 In conclusion, several lines of evidence provided in the present study strongly suggest that the effects observed using NO donors are induced by NO.
BK Channel Limits the Anticontractile Effect of NO
The data of the present study show that NO produces a concentration-dependent shift of the methoxamine concentration-response relationship to the right, which equals an anticontractile effect. Many previous investigations reported that NO produces vasodilation. 3 This strongly supports our findings demonstrating an anticontractile effect of NO.
However, our observations about the contribution of the BK channel to the anticontractile effect of NO were completely unexpected. Previously, a substantial number of studies provided evidence that BK channels mediate NOinduced vasodilation [8] [9] [10] [11] (additional studies listed and discussed by Tanaka et al 12 ) . A few studies reported that BK channels do not contribute to NO-induced vasodilation. [13] [14] [15] [16] The data of the present study show that the anticontractile effect of NO was greater when the BK channel was blocked. In addition, we observed that the functional availability of the BK channel was decreased in the presence of NO. Most important, these findings were observed on 2 different vessel preparations in 2 species, the rat and the mouse. Thus, the data of the present study suggest the new alternative idea that BK channels can limit the anticontractile effect of NO. An alternative analysis of the data provided more insight. This analysis showed that the SNP-induced relaxation is smaller in the presence of iberiotoxin ( Figure S12 ), suggesting that BK channels facilitate NO-induced vasodilation. There is an important limitation with this alternative approach. With this approach, the effect of NO is studied on the basis of a single initial contractile state at a high contraction level. There, NO produced only a small decrease in [Ca 2+ ] i
( Figure 4B at 10 À6 mol/L methoxamine). In contrast, in the present study, vessels were contracted from full relaxation to maximal contraction, and the effect of NO was investigated on the basis of the full range of vessel contractility. There, NO generated a considerable decrease in [Ca 2+ ] i ( Figure 4B ).
Thus, the difference in the effect of NO on [Ca 2+ ] i may be the reason for obtaining 2 contradictory conclusions. The latter idea is emphasized by the following mechanistic considerations. At a high contraction level, NO induces a PKGmediated increase in BK channel activity, well established by many studies, 1, 5, 6 that is stronger than the small [Ca 2+ ] i decrease-mediated decrease of BK channel activity. The overall effect of both is an activation of the BK channel, consistent with the conclusion reached with the alternative approach that BK channels facilitate NO-induced vasodilation ( Figure 7A ). With the approach of the present study, especially at lower levels of contractility, NO induces a PKGmediated increase in BK channel activity that is weaker than the large [Ca 2+ ] i decrease-mediated decrease in BK channel activity. The overall effect of both is a reduction of BK channel activity, consistent with the conclusion reached in this study: that BK channels limit the anticontractile effect of NO ( Figure 7B) . Thus, the effect of NO on the BK channel seems to be mediated by a signaling pathway consisting of 2 simultaneously activated branches: 1 increasing and 1 decreasing BK channel activity, where a decrease in channel activity prevails when the full range of vessel contractility is considered. Because a high contraction level was used in most previous studies, the role of a decrease in [Ca 2+ ] i for BK channel functional availability during NO-induced vasodilation was underestimated. Thus, the existence of opposing conclusions reached in this and in previous studies is not contradictory, but rather reflects a common mechanism explored at different conditions as related to the level of preconstriction used.
In conclusion, the data of the present study promote the new idea that the BK channel limits the anticontractile effect of NO, especially at lower levels of contractility, where NO induces a strong decrease of Third, for the reduction of VOC activity by NO, it should be considered that NO could produce this effect indirectly, mediated by cell membrane hyperpolarization in response to an NO-induced opening of non-BK potassium channels, as observed previously. 39 However, the anticontractile effect of NO and its action on the functional availability of the BK channel were not altered when most non-BK potassium channels known to be expressed in vascular smooth muscle were inhibited by a blocker mixture (containing the Kv1 channel blocker diphenyl phosphine oxide-1, 40 the Kv2 channel blocker stromatoxin, 41 the Kv7 channel blocker XE991, 42 the Kir2 channel blocker barium chloride, 43 and the Kir6 channel blocker glibenclamide 44 ). In addition, NO produced considerable decreases in [Ca 2+ ] i when potassium channels, including BK channels, were either functionally silenced by precontracting vessels with 120 mmol/L KCl or inhibited by the previously mentioned blocker mixture including iberiotoxin. These experimental conditions eliminate indirect potassium channel-mediated effects of NO on VOCs. Thus, NO reduces VOC activity by a mechanism independent of changes in membrane potential in response to an NOinduced activation of non-BK potassium channels. This mechanism most likely involves soluble guanylyl cyclase and PKG, according to the data presented in this study and to previous findings showing a PKG-induced inhibition of L-type VOCs in isolated vascular smooth muscle cells. 51, 52 The details of this mechanism are beyond the focus of the present study and have to be addressed in future studies. Finally, this study provides another important piece of evidence supporting the idea that an NO-induced reduction of calcium influx via VOC enables the BK channel to limit the anticontractile effect of NO. Namely, in BK channel b1-subunit-deficient mice, in which the BK channel cannot respond to NO-induced reductions of calcium influx because of a considerably decreased calcium sensitivity of the BK channel, 17 the anticontractile effect of NO, and its action on the functional availability of the BK channel were no longer affected by iberiotoxin.
In conclusion, the data of the present study show that an NOinduced reduction of calcium influx via L-type VOCs leads to a decrease of BK channel activity, which limits the anticontractile effect of NO, especially at lower levels of contractility.
This study demonstrates, first, that continuously present NO donors evoke a strong anticontractile effect on rat and mouse arteries, which is induced by NO. Second, it shows that the iberiotoxin-induced augmentation of the anticontractile effect of NO is associated with an NO-induced reduction of the effect of iberiotoxin over almost the whole range of vessel contractility, whereas activation of BK channels facilitates NO-induced vasodilation only at high contraction levels. Finally, it reveals that NO evokes a reduction of calcium influx via L-type calcium channels that may enable the BK channel to limit the anticontractile effect of NO, especially at lower levels of contractility.
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